Entering text into the input field will update the search result below

Armata Pharmaceuticals GAAP EPS of -$0.40, revenue of $0.79M

May 11, 2023 5:46 PM ETArmata Pharmaceuticals, Inc. (ARMP) StockBy: Urvi Shah, SA News Editor
  • Armata Pharmaceuticals press release (NYSE:ARMP): Q1 GAAP EPS of -$0.40.
  • Revenue of $0.79M (-35.8% Y/Y).
  • Cash and Equivalents. As of March 31, 2023, Armata held approximately $25.1 million of unrestricted cash and cash equivalents, as compared to $14.9 million as of December 31, 2022.  

  • As of May 5, 2023, there were approximately 36.1 million shares of common stock outstanding.  

Recommended For You

More Trending News

About ARMP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ARMP--
Armata Pharmaceuticals, Inc.